Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

qPSMA: a semi-automatic software for whole-body tumor burden assessment in prostate cancer using 68Ga-PSMA11 PET/CT.

Gafita A, Bieth M, Kroenke M, Tetteh G, Guenther E, Menze B, Weber WA, Eiber M.

J Nucl Med. 2019 Mar 8. pii: jnumed.118.224055. doi: 10.2967/jnumed.118.224055. [Epub ahead of print]

PMID:
30850484
2.

Voxel based comparison and texture analysis of 18F-FDG and 18F-FMISO PET of patients with head-and-neck cancer.

Kroenke M, Hirata K, Gafita A, Watanabe S, Okamoto S, Magota K, Shiga T, Kuge Y, Tamaki N.

PLoS One. 2019 Feb 28;14(2):e0213111. doi: 10.1371/journal.pone.0213111. eCollection 2019.

3.

Renal Mucinous Tubular and Spindle Cell Carcinoma Shows a High Uptake on 18F-FDG PET/CT.

Furuya S, Manabe O, Nanbu T, Yamashita N, Shinnno Y, Kasai K, Kroenke M, Tamaki N.

Intern Med. 2018 Apr 15;57(8):1131-1134. doi: 10.2169/internalmedicine.9523-17. Epub 2017 Dec 27.

4.

Quantification of myocardial blood flow with 11C-hydroxyephedrine dynamic PET: comparison with 15O-H2O PET.

Hiroshima Y, Manabe O, Naya M, Tomiyama Y, Magota K, Obara M, Aikawa T, Oyama-Manabe N, Yoshinaga K, Hirata K, Kroenke M, Tamaki N, Katoh C.

J Nucl Cardiol. 2017 Dec 21. doi: 10.1007/s12350-017-1140-4. [Epub ahead of print]

PMID:
29270771
5.

Volume-based glucose metabolic analysis of FDG PET/CT: The optimum threshold and conditions to suppress physiological myocardial uptake.

Manabe O, Kroenke M, Aikawa T, Murayama A, Naya M, Masuda A, Oyama-Manabe N, Hirata K, Watanabe S, Shiga T, Katoh C, Tamaki N.

J Nucl Cardiol. 2019 Jun;26(3):909-918. doi: 10.1007/s12350-017-1122-6. Epub 2017 Dec 14.

PMID:
29243072
6.

Assay signal as an alternative to titer for assessment of magnitude of an antidrug antibody response.

Starcevic Manning M, Kroenke MA, Lee SA, Harrison SE, Hoofring SA, Mytych DT, Jawa V.

Bioanalysis. 2017 Dec;9(23):1849-1858. doi: 10.4155/bio-2017-0185. Epub 2017 Oct 12.

7.

Breast cancer detected as an incidental finding on 99mTc-MIBI scintigraphy.

Homma T, Manabe O, Ichinokawa K, Yamashita H, Oyama-Manabe N, Kato F, Hirata K, Kroenke M, Tamaki N.

Acta Radiol Open. 2017 Jul 25;6(7):2058460117715665. doi: 10.1177/2058460117715665. eCollection 2017 Jul.

8.

PET/CT scanning with 3D acquisition is feasible for quantifying myocardial blood flow when diagnosing coronary artery disease.

Manabe O, Naya M, Aikawa T, Obara M, Magota K, Kroenke M, Oyama-Manabe N, Hirata K, Shinyama D, Katoh C, Tamaki N.

EJNMMI Res. 2017 Dec;7(1):52. doi: 10.1186/s13550-017-0296-x. Epub 2017 Jun 5.

9.

Clinical immunogenicity of the d-amino acid peptide therapeutic etelcalcetide: Method development challenges and anti-drug antibody clinical impact assessments.

Kroenke MA, Weeraratne DK, Deng H, Sloey B, Subramanian R, Wu B, Serenko M, Hock MB.

J Immunol Methods. 2017 Jun;445:37-44. doi: 10.1016/j.jim.2017.03.005. Epub 2017 Mar 6.

PMID:
28274835
10.

A Proposal to Redefine Clinical Immunogenicity Assessment.

Mytych DT, Hock MB, Kroenke M, Jawa V, Kaliyaperumal A, Zhou Y.

AAPS J. 2017 May;19(3):599-602. doi: 10.1208/s12248-017-0059-7. Epub 2017 Feb 28.

PMID:
28247192
11.

BCL6 orchestrates Tfh cell differentiation via multiple distinct mechanisms.

Hatzi K, Nance JP, Kroenke MA, Bothwell M, Haddad EK, Melnick A, Crotty S.

J Exp Med. 2015 Apr 6;212(4):539-53. doi: 10.1084/jem.20141380. Epub 2015 Mar 30.

12.

Characterization of the isomeric configuration and impurities of (Z)-endoxifen by 2D NMR, high resolution LC⬜MS, and quantitative HPLC analysis.

Elkins P, Coleman D, Burgess J, Gardner M, Hines J, Scott B, Kroenke M, Larson J, Lightner M, Turner G, White J, Liu P.

J Pharm Biomed Anal. 2014 Jan;88:174-9. doi: 10.1016/j.jpba.2013.07.010. Epub 2013 Jul 24.

13.

Human circulating PD-1+CXCR3-CXCR5+ memory Tfh cells are highly functional and correlate with broadly neutralizing HIV antibody responses.

Locci M, Havenar-Daughton C, Landais E, Wu J, Kroenke MA, Arlehamn CL, Su LF, Cubas R, Davis MM, Sette A, Haddad EK; International AIDS Vaccine Initiative Protocol C Principal Investigators, Poignard P, Crotty S.

Immunity. 2013 Oct 17;39(4):758-69. doi: 10.1016/j.immuni.2013.08.031. Epub 2013 Sep 12.

14.

Development and optimization of neutralizing antibody assays to monitor clinical immunogenicity.

Civoli F, Kroenke MA, Reynhardt K, Zhuang Y, Kaliyaperumal A, Gupta S.

Bioanalysis. 2012 Nov;4(22):2725-35. doi: 10.4155/bio.12.239. Review.

PMID:
23210655
15.

Bcl6 and Maf cooperate to instruct human follicular helper CD4 T cell differentiation.

Kroenke MA, Eto D, Locci M, Cho M, Davidson T, Haddad EK, Crotty S.

J Immunol. 2012 Apr 15;188(8):3734-44. doi: 10.4049/jimmunol.1103246. Epub 2012 Mar 16.

16.

IL-23 modulated myelin-specific T cells induce EAE via an IFNγ driven, IL-17 independent pathway.

Kroenke MA, Segal BM.

Brain Behav Immun. 2011 Jul;25(5):932-7. doi: 10.1016/j.bbi.2010.10.001. Epub 2010 Oct 15.

17.

EAE mediated by a non-IFN-γ/non-IL-17 pathway.

Kroenke MA, Chensue SW, Segal BM.

Eur J Immunol. 2010 Aug;40(8):2340-8. doi: 10.1002/eji.201040489.

18.

GM-CSF-dependent, CD103+ dermal dendritic cells play a critical role in Th effector cell differentiation after subcutaneous immunization.

King IL, Kroenke MA, Segal BM.

J Exp Med. 2010 May 10;207(5):953-61. doi: 10.1084/jem.20091844. Epub 2010 Apr 26.

19.

Measuring and distilling the impact of pain.

Kroenke MD.

Pain. 2009 Mar;142(1-2):7-8. doi: 10.1016/j.pain.2009.01.012. Epub 2009 Feb 6. No abstract available.

PMID:
19201095
20.

IL-12- and IL-23-modulated T cells induce distinct types of EAE based on histology, CNS chemokine profile, and response to cytokine inhibition.

Kroenke MA, Carlson TJ, Andjelkovic AV, Segal BM.

J Exp Med. 2008 Jul 7;205(7):1535-41. doi: 10.1084/jem.20080159. Epub 2008 Jun 23.

21.

The Th17-ELR+ CXC chemokine pathway is essential for the development of central nervous system autoimmune disease.

Carlson T, Kroenke M, Rao P, Lane TE, Segal B.

J Exp Med. 2008 Apr 14;205(4):811-23. doi: 10.1084/jem.20072404. Epub 2008 Mar 17.

23.

Effect of B7-2 and CD40 signals from activated antigen-presenting cells on the ability of zwitterionic polysaccharides to induce T-Cell stimulation.

Stephen TL, Niemeyer M, Tzianabos AO, Kroenke M, Kasper DL, Kalka-Moll WM.

Infect Immun. 2005 Apr;73(4):2184-9.

Supplemental Content

Loading ...
Support Center